.webp?width=217&height=60&name=Screenpoint-Med%20(1).webp "Screen Point Medical")
MASAI RCT: 12% reduction in interval cancer rate using Transpara
%20(1).png)
MASAI RCT: 12% reduction in interval cancer rate using Transpara
Transpara® Breast AI Selected for $16M PRISM Randomized Controlled Trial in USA
.png)
Transpara® Breast AI Selected for $16M PRISM Randomized Controlled Trial in USA
ScreenPoint Medical Enables Transpara® Breast AI within Precision Imaging Network, part of Microsoft for Healthcare
.png)
ScreenPoint Medical Enables Transpara® Breast AI within Precision Imaging Network, part of Microsoft for Healthcare
Podcast: ScreenPoint Co-Founder Talks Future of Breast Cancer Screening
.png)
Podcast: ScreenPoint Co-Founder Talks Future of Breast Cancer Screening
Nico Karssemeijer, Chief Science Officer and Co-Founder of ScreenPoint Medical, joins Impact AI podcast to discuss how his team is revolutionizing breast cancer screening through cutting-edge AI.
June 10, 2025